1. Protein kinase inhibitors in traumatic brain injury and repair: New roles of nanomedicine
   Hari Shanker Sharma et al, 2020, Neuropharmacology of Neuroprotection CrossRef
2. The emerging era of personalized medicine in advanced colorectal cancer
   Claudia W K Wu et al, 2022, Journal of Gastroenterology and Hepatology CrossRef
3. Delineation of gastric tumors with activated ERK/MAPK signaling cascades for the development of targeted therapeutics
   Jaishree Pandian et al, 2022, Experimental Cell Research CrossRef
4. The recent advances of PD-1 and PD-L1 checkpoint signaling inhibition for breast cancer immunotherapy
   Patience Setordzi et al, 2021, European Journal of Pharmacology CrossRef
5. B7 homolog 3 induces lung metastasis of breast cancer through Raf/MEK/ERK axis
   Shuai Wang et al, 2022, Breast Cancer Research and Treatment CrossRef
6. A Comprehensive Review on MAPK: A Promising Therapeutic Target in Cancer
   Cornelia Braicu et al, 2019, Cancers CrossRef
7. Mini review: The FDA-approved prescription drugs that target the MAPK signaling pathway in women with breast cancer
   Fatemeh Khojasteh Poor et al, 2021, Breast Disease CrossRef
8. Combined treatment with auranofin and trametinib induces synergistic apoptosis in breast cancer cells
   Min-Kyung Joo et al, 2021, Journal of Toxicology and Environmental Health, Part A CrossRef
9. Macrophage induced ERK-TGF-β1 signaling in MCF7 breast cancer cells result in reversible cancer stem cell plasticity and epithelial mesenchymal transition
   Priya Kundu et al, 2022, Biochimica et Biophysica Acta (BBA) - General Subjects CrossRef
10. Targeting KRAS in Cancer: Promising Therapeutic Strategies
    Lisa Maria Mustachio et al, 2021, Cancers CrossRef
11. Oncogenic gain of function due to p53 amyloids occurs through aberrant alteration of cell cycle and proliferation
    Ambuja Navalkar et al, 2022, Journal of Cell Science CrossRef
12. Knockdown of RNF6 inhibits HeLa cervical cancer cell growth via suppression of MAPK/ERK signaling
    Kang Zhu et al, 2021, FEBS Open Bio CrossRef
13. METTL3 stabilization by PIN1 promotes breast tumorigenesis via enhanced m6A-dependent translation
    Poshan Yugal Bhattarai et al, 2023, Oncogene CrossRef
14. Activation of the EGFR/PI3K/AKT pathway limits the efficacy of trametinib treatment in head and neck cancer
    Ofra Novoplansky et al, 2023, Molecular Oncology CrossRef
15. Identifying drivers of breast cancer metastasis in progressively invasive subpopulations of zebrafish-xenografted MDA-MB-231
    Jerry Xiao et al, 2022, Molecular Biomedicine CrossRef
16. Suppression of epidermal growth factor receptor‐mediated β‐catenin nuclear accumulation enhances the anti‐tumor activity of phosphoinositide 3‐kinase inhibitor in breast cancer
    Jie Niu et al, 2019, Cell Biology International CrossRef
17. FAM46B inhibits cell proliferation and cell cycle progression in prostate cancer through ubiquitination of β-catenin
    Tao Liang et al, 2018, Experimental & Molecular Medicine CrossRef
18. BarH-like homeobox 1 induces the progression of cell malignant phenotype in endometrial carcinoma through the regulation of ERK/MEK signaling pathway
    Yuanyuan Lu et al, 2021, Reproductive Biology CrossRef
19. Retracted: CCR5 silencing reduces inflammatory response, inhibits viability, and promotes apoptosis of synovial cells in rat models of rheumatoid arthritis through the MAPK signaling pathway
    You‐Yu Lan et al, 2019, Journal of Cellular Physiology CrossRef
20. Antitumor Effect of Metformin in Combination with Binimetinib on Melanoma Cells
    Eunsung Lee et al, 2021, Development & Reproduction CrossRef
21. Silencing of purinergic receptor P2Y2 inhibited enteric neural crest cell proliferation, invasion and migration via suppressing ERK signaling pathway in Hirschsprung disease
    Dengrui Liu et al, 2023, 3 Biotech CrossRef
22. Effective Treatment of Metastatic Melanoma by Combining MAPK and PI3K Signaling Pathway Inhibitors
    Synnøve Nymark Aasen et al, 2019, International Journal of Molecular Sciences CrossRef
23. Serotonin-induced miR-221/222 contribute to the activation of hepatic stellate cells
    Yi Xiang et al, 2020, Biologia CrossRef
24. HNRNPA2B1 regulates tamoxifen- and fulvestrant-sensitivity and hallmarks of endocrine resistance in breast cancer cells
    Belinda J. Petri et al, 2021, Cancer Letters CrossRef
25. DKK1 inhibits breast cancer cell migration and invasion through suppression of β-catenin/MMP7 signaling pathway
    Jie Niu et al, 2019, Cancer Cell International CrossRef
26. Hyperactivation of MAPK Induces Tamoxifen Resistance in SPRED2-Deficient ERα-Positive Breast Cancer
    Vasiliki Vafeiadou et al, 2022, Cancers CrossRef